导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -20.20% | 4395/4773 |
| 近一周 | -3.69% | 4453/5462 |
| 近一月 | -11.04% | 5255/5421 |
| 近一季 | -22.60% | 5130/5209 |
| 近半年 | -22.09% | 4498/4920 |
| 近一年 | -11.37% | 3496/4366 |
| 近两年 | 64.90% | 1076/2954 |
| 近三年 | 14.90% | 1638/2253 |
| 成立以来 | 150.35% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.07% 2098/4961 |
0.84% 3114/5312 |
- - |
- - |
| 2025 | 57.36% 286/4813 |
6.91% 551/3635 |
-0.85% 3043/4076 |
50.87% 289/4524 |
-1.61% 2976/4813 |
| 2024 | 0.39% 2075/3463 |
-7.54% 2168/2808 |
-10.11% 2421/3014 |
23.28% 405/3129 |
-2.02% 1930/3463 |
| 2023 | -28.23% 2033/2656 |
-2.45% 1984/2280 |
-5.51% 1479/2385 |
-15.92% 2240/2515 |
-7.40% 2137/2655 |
| 2022 | -28.91% 1583/2207 |
-17.48% 1213/1919 |
20.56% 43/2016 |
-24.18% 1983/2113 |
-5.74% 1952/2208 |
| 2021 | 43.44% 17/1822 |
-12.31% 1145/1255 |
45.90% 6/1330 |
13.63% 88/1466 |
-1.33% 1353/1822 |
| 2020 | - - |
- - |
31.80% 37/1067 |
14.65% 269/1164 |
51.54% 2/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国泰中证新能源汽车ETF VS. 长安沪深300非周期A(740101) |